BNP Paribas Asset Management
CLOV icon

BNP Paribas Asset Management’s Clover Health Investments CLOV Stock Holding History

BNP Paribas Asset Management’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.5K Sell
6,397
-65
-1% -$221 ﹤0.01% 1908
2026
Q1 		$11.4K Buy
6,462
+1,222
+23% +$2.65K ﹤0.01% 2180
2025
Q4 		$12K Buy
5,240
+1,626
+45% +$4.44K ﹤0.01% 2091
2025
Q3 		$11K Hold
3,614
– – ﹤0.01% 1593
2025
Q2 		$10K Buy
+3,614
New +$11.9K ﹤0.01% 1763

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BNP Paribas Asset Management's CLOV Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Clover Health Investments (CLOV) stake by 1% in Q2 2026, selling an estimated $221 and leaving 6,397 shares worth $33.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1908.

BNP Paribas Asset Management first reported a position in CLOV in Q2 2025 and has held it in 5 quarters since. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • BNP Paribas Asset Management held 6,397 shares of Clover Health Investments worth $33.5K as of Q2 2026.
  • BNP Paribas Asset Management sold 65 Clover Health Investments shares in Q2 2026, an estimated $221.
  • Clover Health Investments made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1908 holding.
  • BNP Paribas Asset Management first reported a position in Clover Health Investments in Q2 2025 and has held it in 5 quarters since.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.